Delivery Order SPE2DB20D1102-SPE2DB24FC6LX
- Not listed
- The federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, in the amount of $10,888.26 under a firm fixed-price delivery order. The contract has an ultimate completion date of July 17, 2025 and was not set-aside for any specific business category....
- This federal contract award is for the supply of EPINEPHRINE 0.3 MG AUTO-INJECT 2S to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on May 7, 2024 as a Delivery Order with a Firm Fixed Price and a ceiling value of $1,412.26. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
- This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $2,812.19. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of September 26, 2023. AmerisourceBergen holds a significant Indefinite Delivery...
- The federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S to the Defense Logistics Agency (DLA). The $2,081.46 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor that provides medical products to federal government agencies, particularly military and veterans' healthcare programs. The contract has an ultimate completion date of March 27, 2025 and is not designated as a set-aside. Amerisourcebergen holds a...
- This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a ceiling value of $2,305.43 and a period of performance through April 10, 2024. Amerisourcebergen Drug...
- This federal contract award is for the delivery of 4,566,077,688 units of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical pharmaceutical product, to the Defense Logistics Agency (DLA) under a firm fixed price delivery order. The contractor, Amerisourcebergen Drug Corp, is a major pharmaceutical distributor and has been awarded this $3,301.26 contract with a completion date of October 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999...
- This federal contract award is for the delivery of 4,564,260 units of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The $2,990.60 fixed-price contract was awarded to Amerisourcebergen Drug Corp, a division of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical for up to $999,999,999.00 through December...
- This federal contract award is for the delivery of Epinephrine 0.3 mg Auto-Injectors to the Defense Logistics Agency (DLA). The contract, valued at $2,725.08, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on April 29, 2024. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 30, 2024. This award is associated with Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $1,794.36, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on a firm-fixed-price basis. The contract is a delivery order that does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to...
- This federal contract award is for the delivery of 4,566,708,687 units of epinephrine 0.3 mg auto-injectors. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for a firm fixed price of $2,642.89. The contract has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DB20D1102Indefinite Delivery Contract
- SPE2DB20D1102-SPE2DB24FC6LXDelivery Order
This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $5,233.55, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract awarded on May 24, 2024 has a completion date of May 28, 2024 and does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 5/24/24 |